CureVac Funding: $975M Raised, Series F (2020)

CureVac funding overview

CureVac is based in Tübingen, Germany. CureVac has raised $975M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series F announced in June 2020. The round record for CureVac runs through 2020; nothing later has been disclosed. Investors on record include Qatar Investment Authority, GSK, Bundesregierung, European Investment Bank, CEPI, dievini Hopp BioTech holding and 2 others. 8 distinct backers are named across the disclosed rounds.

CureVac at a glance

Total raised: $975M
Latest round: Series F
Latest round date: June 2020
Headquarters: Tübingen, Germany
Notable investors: Qatar Investment Authority, GSK, Bundesregierung, European Investment Bank, CEPI, dievini Hopp BioTech holding, Bill & Melinda Gates Foundation, Kreditanstalt für Wiederaufbau

Frequently asked about CureVac funding

How much has CureVac raised?: CureVac has raised $975M in total disclosed funding across the rounds on record.
Who has invested in CureVac?: Qatar Investment Authority, GSK, Bundesregierung, European Investment Bank, CEPI, dievini Hopp BioTech holding are named among the investors backing CureVac.
What was the latest CureVac funding round?: The most recent disclosed round is a Series F, announced in June 2020.
Where is CureVac based?: CureVac is based in Tübingen, Germany.
When did CureVac last raise?: The last disclosed CureVac round closed in June 2020 at Series F.

Every CureVac figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Tübingen at a similar stage.

CureVac Funding: $975M Raised, Series F (2020)

CureVac funding overview

CureVac at a glance

Frequently asked about CureVac funding

Companies related to CureVac (20)

Browse related funding lists (5)